JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
Pacer Trendpilot US Large Cap ETF
PTLC
$3.39B
| $3.69M | ﹤0.01% |
97,001
+84,237
| +660% | +$3.14M |
2022 Q2
3 quarters
|
|
2927
REX American Resources
REX
$1.46B
| $3.69M | ﹤0.01% |
258,226
-93,196
| -27% | -$1.47M |
2013 Q2
39 quarters
|
|
|
EGRX
2928
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.69M | ﹤0.01% |
130,063
+18,648
| +17% | +$554K |
2017 Q3
22 quarters
|
|
2929
LSI Industries
LYTS
$780M
| $3.69M | ﹤0.01% |
264,704
+251,563
| +1,914% | +$3.48M |
2020 Q2
11 quarters
|
|
2930
WisdomTree True Developed International Fund
DOL
$833M
| $3.68M | ﹤0.01% |
78,876
+8,132
| +11% | +$378K |
2022 Q1
4 quarters
|
|
2931
Establishment Labs
ESTA
$1.95B
| $3.68M | ﹤0.01% |
54,356
+10,413
| +24% | +$714K |
2021 Q2
7 quarters
|
|
2932
Fastly Inc
FSLY
$4.06B
| $3.67M | ﹤0.01% |
206,677
+25,243
| +14% | +$321K |
2019 Q4
13 quarters
|
|
2933
ProShares MSCI Transformational Changes ETF
ANEW
$8.18M
| $3.67M | ﹤0.01% |
105,298
-300
| -0.3% | -$10.1K |
2021 Q1
8 quarters
|
|
2934
Myriad Genetics
MYGN
$409M
| $3.67M | ﹤0.01% |
157,862
+17,176
| +12% | +$349K |
2013 Q2
39 quarters
|
|
2935
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.33B
| $3.67M | ﹤0.01% |
37,890
+15,083
| +66% | +$1.44M |
2015 Q2
31 quarters
|
|
2936
iShares US Healthcare Providers ETF
IHF
$1.38B
| $3.67M | ﹤0.01% |
74,135
-950
| -1% | -$48.8K |
2013 Q2
39 quarters
|
|
|
ZEUS
2937
DELISTED
Olympic Steel
ZEUS
| $3.67M | ﹤0.01% |
70,211
-8,204
| -10% | -$379K |
2016 Q1
28 quarters
|
|
2938
Bilibili
BILI
$6.14B
| $3.66M | ﹤0.01% |
155,752
-2,123
| -1% | -$50.5K |
2018 Q1
20 quarters
|
|
2939
PUT
Intercontinental Exchange
ICE
$86.2B
| $3.66M | ﹤0.01% |
35,100
-93,900
| -73% | -$9.78M |
2021 Q1
8 quarters
|
|
|
KDNY
2940
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.66M | ﹤0.01% |
157,964
+5,979
| +4% | +$143K |
2015 Q2
31 quarters
|
|
2941
Goldman Sachs MarketBeta International Equity ETF
GSID
$1.07B
| $3.65M | ﹤0.01% |
72,099
-3,975
| -5% | -$198K |
2022 Q4
1 quarter
|
|
2942
CALL
Deere & Co
DE
$184B
| $3.63M | ﹤0.01% |
8,800
-18,600
| -68% | -$7.7M |
2021 Q1
8 quarters
|
|
2943
Cinemark Holdings
CNK
$4.09B
| $3.61M | ﹤0.01% |
244,321
+133,315
| +120% | +$1.62M |
2013 Q2
39 quarters
|
|
|
HJEN
2944
DELISTED
Direxion Hydrogen ETF
HJEN
| $3.61M | ﹤0.01% |
250,000
| – | – |
2021 Q1
8 quarters
|
|
|
TCN
2945
DELISTED
Tricon Residential Inc.
TCN
| $3.6M | ﹤0.01% |
465,064
+60,272
| +15% | +$496K |
2021 Q4
5 quarters
|
|
2946
Schwab U.S Small- Cap ETF
SCHA
$22B
| $3.6M | ﹤0.01% |
171,514
-97,838
| -36% | -$2.1M |
2020 Q3
10 quarters
|
|
|
DOOR
2947
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $3.59M | ﹤0.01% |
39,560
+486
| +1% | +$42.8K |
2014 Q4
33 quarters
|
|
2948
Schwab US Broad Market ETF
SCHB
$45.4B
| $3.59M | ﹤0.01% |
225,003
-30,897
| -12% | -$483K |
2017 Q1
24 quarters
|
|
2949
AppFolio
APPF
$7.2B
| $3.59M | ﹤0.01% |
28,832
+6,193
| +27% | +$747K |
2017 Q3
22 quarters
|
|
2950
ADT
ADT
$4.65B
| $3.58M | ﹤0.01% |
495,743
+317,440
| +178% | +$2.59M |
2018 Q1
20 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.